Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept

1 Mar 1998

Abstract excerpt

OBJECTIVE: This is the first part of a bipartite review that summarizes the rising knowledge on the molecular mechanisms underlying the action of advanced glycation endproducts (AGEs) and their contribution to diabetic complications and vascular disease. While the first part presented here focusses on AGE formation, the second part will describe the AGE-protein/receptor interactions and their role in mediating...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Glycation End Products research
Share to Aldose Reductase and Taurine
Share to Flavonoids in Medical Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 9659442
DOI: 10.1016/s0008-6363(97)00233-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE conceptPMID 9659442Read ↗

A Role for Advanced Glycation End Products in Molecular AgeingSemantic proximity Read ↗

Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.Semantic proximity Read ↗

Diabetic threesome (hyperglycaemia, renal function and nutrition) and advanced glycation end products: evidence for the multiple-hit agent?Semantic proximity Read ↗

The Role of Advanced Glycation End Products in Aging and Metabolic Diseases: Bridging Association and CausalitySemantic proximity Read ↗

Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders.Semantic proximity Read ↗

Impact of Dietary Advanced Glycation End Products on Female Reproduction: Review of Potential Mechanistic PathwaysSemantic proximity Read ↗

Multifactorial Therapeutic Strategies Targeting Advanced Glycation End-Products, Oxidative Stress, and Metabolic Dysfunction in Alzheimer's DiseaseSemantic proximity Read ↗

Methylglyoxal in Cardiometabolic Disorders – Routes Leading to Pathology – Counterbalanced by Treatment StrategiesSemantic proximity Read ↗

Advanced glycation end products as environmental risk factors for the development of type 1 diabetes.Semantic proximity Read ↗

Oxidation as “The Stress of Life”Semantic proximity Read ↗

The Effect of Age on the Progression and Severity of Type 1 Diabetes: Potential Effects on Disease MechanismsSemantic proximity Read ↗

Discovery of Glycation-Derived Crosslinks at ArginineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.